Are Chemotherapy Patients’ HRQoL Importance Weights Consistent with Linear Scoring Rules? A Stated-choice Approach
- 1 March 2006
- journal article
- Published by Springer Science and Business Media LLC in Quality of Life Research
- Vol. 15 (2), 285-298
- https://doi.org/10.1007/s11136-005-0581-4
Abstract
Objective: To compare a linear scoring rule with the subjective importance of different domain and symptom levels of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (EORTC QLQ-C30) among patients undergoing chemotherapy. Methods: Using a stated-choice or choice-format conjoint analysis survey instrument, we elicited patient preferences for varying levels of physical, role, social, emotional, and cognitive function along with chemotherapy-related side effects and financial difficulties. A total of 375 patients completed the questionnaire: 159 breast cancer, 117 colorectal cancer, 99 non-small-cell lung cancer; and 21 with unknown tumor type. Constrained maximum likelihood estimates were used to estimate relative importance weights for each level of each domain and symptom. Results: Summary HRQoL measures generally presume that differences among Likert categories are equally important to patients within and across outcomes. Our results indicate strong non-linearities both within and across domain and symptom categories. Improvements from severe pain to mild pain, severe fatigue to no fatigue, and severe social limitations to moderate social limitations are all about twice as important as no work to limited work in the Role domain. Conclusions: Our results indicate large differences in the impact of individual domains and symptoms on patient perceptions of well-being. Most cancer patients are likely to be less concerned about specific symptoms than the impact of those symptoms on their ability to function physically, socially, and in their daily roles.Keywords
This publication has 24 references indexed in Scilit:
- Development and validation of the health assessment questionnaire II: A revised version of the health assessment questionnaireArthritis & Rheumatism, 2004
- Modeling Choice Behavior for New Pharmaceutical ProductsValue in Health, 2001
- Willingness to pay for improved respiratory and cardiovascular health: a multiple-format, stated-preference approachHealth Economics, 2000
- THE USE OF CONJOINT ANALYSIS TO ELICIT WILLINGNESS-TO-PAY VALUESInternational Journal of Technology Assessment in Health Care, 2000
- Rasch analysis of the Western Ontario MacMaster Questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgiaAnnals Of The Rheumatic Diseases, 1999
- Using Conjoint Analysis to Evaluate Health State PreferencesDrug Information Journal, 1999
- Eliciting Stated Health PreferencesMedical Decision Making, 1998
- Estimating Stated Preferences with Rated-Pair Data: Environmental, Health, and Employment Effects of Energy ProgramsJournal of Environmental Economics and Management, 1997
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Commercial Use of Conjoint Analysis: An UpdateJournal of Marketing, 1989